Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Drugs for preventing red blood cell dehydration in people with sickle cell disease

Esta versión no es la más reciente

Información

DOI:
https://doi.org/10.1002/14651858.CD003426.pub2Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 17 octubre 2007see what's new
Tipo:
  1. Intervention
Etapa:
  1. Review
Grupo Editorial Cochrane:
  1. Grupo Cochrane de Fibrosis quística y enfermedades genéticas

Copyright:
  1. Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Priya C Singh

    Department of Hematology and Medical Oncology, Thomas Jefferson University Hospital, Philadelphia, USA

  • Samir K Ballas

    Correspondencia a: Department of Medicine, Cardeza Foundation for Hematologic Research, Philadelphia, USA

    [email protected]

Contributions of authors

Review from Issue 4, 2007

Dr Singh is now lead author and updated the review with Dr Samir Ballas (co‐author). Dr Singh acts as guarantor of the review. Dr Singh reviewed the current literature on piracetam and revised the manuscript with advice from Dr Ballas.

Drs Hirst and de Franceschi have stepped down as active authors on this review.

Review up to Issue 3, 2007

The review was conceived by the Cochrane Cystic Fibrosis and Genetic Disorders Group and designed by Dr Hirst (née Riddington).

Dr Hirst and the Cochrane Cystic Fibrosis and Genetic Disorders Group conducted searches for relevant studies.

Dr Hirst and Dr de Franceschi screened, appraised and abstracted data for the review. Additional information from authors was sought by Dr Hirst were necessary.

Data entry was performed by Dr Hirst and interpreted by Dr Hirst with advice from the Cochrane Cystic Fibrosis and Genetic Disorders Group.

Sources of support

Internal sources

  • No sources of support supplied

External sources

  • Department of Health ‐ Research and Development Programme, UK.

Declarations of interest

disponible en

None known.

Acknowledgements

disponible en

We would like to acknowledge the significant contribution made on this review by the original authors ‐ Dr Ceri Hirst and Dr Lucia de Franceschi.

Version history

Published

Title

Stage

Authors

Version

2018 Oct 19

Drugs for preventing red blood cell dehydration in people with sickle cell disease

Review

Srikanth Nagalla, Samir K Ballas

https://doi.org/10.1002/14651858.CD003426.pub6

2016 Mar 04

Drugs for preventing red blood cell dehydration in people with sickle cell disease

Review

Srikanth Nagalla, Samir K Ballas

https://doi.org/10.1002/14651858.CD003426.pub5

2012 Jul 11

Drugs for preventing red blood cell dehydration in people with sickle cell disease

Review

Srikanth Nagalla, Samir K Ballas

https://doi.org/10.1002/14651858.CD003426.pub4

2010 Jan 20

Drugs for preventing red blood cell dehydration in people with sickle cell disease

Review

Srikanth Nagalla, Samir K Ballas

https://doi.org/10.1002/14651858.CD003426.pub3

2007 Oct 17

Drugs for preventing red blood cell dehydration in people with sickle cell disease

Review

Priya C Singh, Samir K Ballas

https://doi.org/10.1002/14651858.CD003426.pub2

2002 Oct 21

Drugs for preventing red blood cell dehydration in people with sickle cell disease

Review

C Riddington, L De Franceschi, Ceri Hirst, Lucia de Franceschi

https://doi.org/10.1002/14651858.CD003426

PICO

Population
Intervention
Comparison
Outcome

El uso y la enseñanza del modelo PICO están muy extendidos en el ámbito de la atención sanitaria basada en la evidencia para formular preguntas y estrategias de búsqueda y para caracterizar estudios o metanálisis clínicos. PICO son las siglas en inglés de cuatro posibles componentes de una pregunta de investigación: paciente, población o problema; intervención; comparación; desenlace (outcome).

Para saber más sobre el uso del modelo PICO, puede consultar el Manual Cochrane.